ABPI statement on biomarker testing

The ABPI commented in support of a call led by the Institute of Cancer Research (ICR) for all cancer patients to be offered genetic testing so they can get the best treatments available for them.  

Dr Jennifer Harris, Director of Research policy at the ABPI said:  

“All patients, including cancer patients, should be able to get the best treatments available for their condition.

“Biomarker tests provide crucial information to help doctors select the treatments that will have the best chance of success in each person.

“Overcoming the barriers to developing and using biomarker tests would be a big step forward for personalised care. We will continue to work with the ICR and other partners to help make this happen.”